Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Staking stablecoins can offer rewards, but there are risks to consider. This intro highlights potential issues and basic protections for stakers.
27,764 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
When a top executive sells stock, investors want to know if it signals trouble or simply personal planning. This arti...
As AI models scale, memory bandwidth becomes the bottleneck. This article digs into Nvidia's role in HBM4, the chatte...
A high-profile estate story can illuminate practical steps you can take to protect loved ones and support causes you ...
Accelerant Holdings has fallen sharply since its IPO, but a major fund just took a sizable stake. This article explai...
Kanen Wealth Management added a substantial stake in Compass, prompting questions about compass stock after kanen. Th...
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Dreaming of easy flights and hotel stays? Credit cards with bonus travel points offers can unlock big-value redemptio...
Looking at how applied optoelectronics (aaoi) earnings shape the stock story? This guide breaks down what to watch in...
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Turning Point Brands stock has surged, even as a prominent fund dumped millions in TPB shares. This article breaks do...
When a large investor opens million position in an industrial REIT, it signals confidence in long-term cash flow and ...